-
Founded in:
1994-06-28 -
Country:
China -
Address:
No. 518, Huaian East Road, Shijiazhuang High-tech Industrial Development Zone -
Tax NO.:
911301001044060055 -
Registered Funds:
950 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Fluconazole |
This product belongs to the azole antifungal drug with a wide antifungal spectrum. It can selectively interfere with the activity of fungal cytochrome P-450 and inhibit the biosynthesis of ergosterol on the fungal cell membrane. It is effective against a variety of fungal infections, including Candida infection, Cryptococcus neoformans infection, Malassezia furfur, Microsporum, etc. The in vivo antibacterial activity is significantly higher than the in vitro effect.
More
This product belongs to the azole antifungal drug with a wide antifungal spectrum. It can selectively interfere with the activity of fungal cytochrome P-450 and inhibit the biosynthesis of ergosterol on the fungal cell membrane. It is effective against a variety of fungal infections, including Candida infection, Cryptococcus neoformans infection, Malassezia furfur, Microsporum, etc. The in vivo antibacterial activity is significantly higher than the in vitro effect. |
86386-73-4 | 69 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cefadroxil |
The first generation of oral cephalosporin has good antibacterial effect on most strains such as penicillinase-producing and non-penicillinase-producing Staphylococcus aureus, coagulase-negative Staphylococcus, Streptococcus pneumoniae, and group A hemolytic Streptococcus. It also has certain antibacterial activity against Escherichia coli, Proteus mirabilis, Salmonella, Shigella, Haemophilus influenzae, and gonococci. Methicillin-resistant Staphylococci, Enterococci, indole-positive Proteus, Enterobacter, Serratia and other Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides fragilis are resistant to this product. Low toxicity, no death was found at high doses, and long-term use did not produce toxic reactions to various tissues and organs.
More
The first generation of oral cephalosporin has good antibacterial effect on most strains such as penicillinase-producing and non-penicillinase-producing Staphylococcus aureus, coagulase-negative Staphylococcus, Streptococcus pneumoniae, and group A hemolytic Streptococcus. It also has certain antibacterial activity against Escherichia coli, Proteus mirabilis, Salmonella, Shigella, Haemophilus influenzae, and gonococci. Methicillin-resistant Staphylococci, Enterococci, indole-positive Proteus, Enterobacter, Serratia and other Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides fragilis are resistant to this product. Low toxicity, no death was found at high doses, and long-term use did not produce toxic reactions to various tissues and organs. |
66592-87-8 | 28 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sodium lactate Ringer's solution |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Pentoxifylline |
By inhibiting phosphodiesterase and activating adenylate cyclase, intracellular cAMP increases, the formation and release of prostaglandins are promoted, the vascular smooth muscle of the arteriolar wall is relaxed, platelet aggregation is inhibited, and partial disaggregation of aggregated platelets is promoted; by increasing the intracellular ATP content, red blood cell stiffness is reduced, and red blood cell deformability is improved; red blood cell aggregation is inhibited; and blood viscosity is reduced, blood flow is promoted, and circulation and nutrition of hypoxic tissues are improved.
More
By inhibiting phosphodiesterase and activating adenylate cyclase, intracellular cAMP increases, the formation and release of prostaglandins are promoted, the vascular smooth muscle of the arteriolar wall is relaxed, platelet aggregation is inhibited, and partial disaggregation of aggregated platelets is promoted; by increasing the intracellular ATP content, red blood cell stiffness is reduced, and red blood cell deformability is improved; red blood cell aggregation is inhibited; and blood viscosity is reduced, blood flow is promoted, and circulation and nutrition of hypoxic tissues are improved. |
6493-05-6 | 41 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| L-Histidine |
Supplement essential amino acids in the body and improve nutritional status; restore the decreased plasma concentration of essential amino acids in chronic renal failure, enhance assimilation, help alleviate uremia symptoms, reduce blood phosphorus, and correct calcium-phosphorus metabolism disorders.
More
Supplement essential amino acids in the body and improve nutritional status; restore the decreased plasma concentration of essential amino acids in chronic renal failure, enhance assimilation, help alleviate uremia symptoms, reduce blood phosphorus, and correct calcium-phosphorus metabolism disorders. |
2.5g | 71-00-1 | 20 |
| L-Isoleucine |
Supplement essential amino acids in the body and improve nutritional status; restore the decreased plasma concentration of essential amino acids in chronic renal failure, enhance assimilation, help alleviate uremia symptoms, reduce blood phosphorus, and correct calcium-phosphorus metabolism disorders.
More
Supplement essential amino acids in the body and improve nutritional status; restore the decreased plasma concentration of essential amino acids in chronic renal failure, enhance assimilation, help alleviate uremia symptoms, reduce blood phosphorus, and correct calcium-phosphorus metabolism disorders. |
5.6g | 73-32-5 | 20 |
| L-Leucine |
Supplement essential amino acids in the body and improve nutritional status; restore the decreased plasma concentration of essential amino acids in chronic renal failure, enhance assimilation, help alleviate uremia symptoms, reduce blood phosphorus, and correct calcium-phosphorus metabolism disorders.
More
Supplement essential amino acids in the body and improve nutritional status; restore the decreased plasma concentration of essential amino acids in chronic renal failure, enhance assimilation, help alleviate uremia symptoms, reduce blood phosphorus, and correct calcium-phosphorus metabolism disorders. |
8.8g | 61-90-5 | 11 |
| L-Lysine Acetate Salt |
Supplement essential amino acids in the body and improve nutritional status; restore the decreased plasma concentration of essential amino acids in chronic renal failure, enhance assimilation, help alleviate uremia symptoms, reduce blood phosphorus, and correct calcium-phosphorus metabolism disorders.
More
Supplement essential amino acids in the body and improve nutritional status; restore the decreased plasma concentration of essential amino acids in chronic renal failure, enhance assimilation, help alleviate uremia symptoms, reduce blood phosphorus, and correct calcium-phosphorus metabolism disorders. |
9.0g | 52315-92-1 | 0 |
| L-Methionine |
Supplement essential amino acids in the body and improve nutritional status; restore the decreased plasma concentration of essential amino acids in chronic renal failure, enhance assimilation, help alleviate uremia symptoms, reduce blood phosphorus, and correct calcium-phosphorus metabolism disorders.
More
Supplement essential amino acids in the body and improve nutritional status; restore the decreased plasma concentration of essential amino acids in chronic renal failure, enhance assimilation, help alleviate uremia symptoms, reduce blood phosphorus, and correct calcium-phosphorus metabolism disorders. |
8.8g | 63-68-3 | 12 |
| L-Phenylalanine |
Supplement essential amino acids in the body and improve nutritional status; restore the decreased plasma concentration of essential amino acids in chronic renal failure, enhance assimilation, help alleviate uremia symptoms, reduce blood phosphorus, and correct calcium-phosphorus metabolism disorders.
More
Supplement essential amino acids in the body and improve nutritional status; restore the decreased plasma concentration of essential amino acids in chronic renal failure, enhance assimilation, help alleviate uremia symptoms, reduce blood phosphorus, and correct calcium-phosphorus metabolism disorders. |
3617-44-5 | 0 |